Abstract
From the organic extracts of two Guam sponges, Rhaphoxya sp., and Suberea sp., determined to have cytotoxic and chemopreventive activities, three new compounds, theonellin isocyanate (1), psammaplysins I and J (5-6), and six previously reported compounds (2-4, 7-9) were isolated and characterised spectroscopically (1H and 13C NMR, MS, IR, UV, [α]D). The two new compounds (5 and 6) isolated from the Rhaphoxya sp., sponge are rare examples of compounds containing a bromotyramine moiety rather than the more usual dibromo-analogue. For the compounds isolated from the Rhaphoxya sp., this is the first report of the known compounds 2-4 being found in a single sponge. For previously reported compounds 2-4 complete unambiguous 1H and 13C NMR data are provided.
It is well accepted that the marine environment is a proven source of molecules without structural precedent,1, 2 of therapeutic agents,1-3 and of products employed by the cosmetics, agricultural and chemical industries.4, 5 Over the past three decades in excess of 22,000 natural products have been isolated from marine organisms.6 The likely reason for this wealth of chemical biodiversity is the fact that they are often produced by sessile life forms found in the oceans. Being fixed or pedestrian yields an organism extremely vulnerable to attack by highly mobile predators if it is not adequately protected. Typically, such organisms, including algae, sea grasses, sponges, tunicates, soft corals and gorgonians, defend themselves chemically. Given that some of these organisms like sponges are among the most ancient metazoan (multicellular) animals, dating back at least 600 million years, it comes as no surprise that these chemical defences are highly evolved. Although still to be defined, it might be that in some cases these defence chemicals may be tailored to defend a given organism from a specific predator meaning those organisms with more than one predatory species can often have a suite of such chemicals.7
With this premise in mind, screening of extracts derived from twilight or disphotic zone organisms, those living between 50 and 1000 m depth, was undertaken to test the theory that those organisms from relatively extreme environments would be at least, if not more, chemically productive than their counterparts found in more accessible regions of the oceans. This prior investigation in our laboratories of the extracts of 65 Twilight Zone sponges, gorgonians, hard corals, and sponge associated bacteria resulted in an extremely high hit rate of 42% of active extracts,8 with a hit rate for sponge and gorgonian extracts being an astonishing 72%.8 Based on these screening results two of 15 sponges were chosen at random for further chemical investigation. Each sponge extract was retested to confirm their bioactivity profiles,8 and subsequently chemically screened for the presence of so-called nuisance compounds, these being usually too toxic or generalist for further development. With this pre-screening completed, compounds were then isolated and assessed to determine which were implicated in, or possibly responsible for, the observed activity with the expectation of finding new natural products chemistry that might warrant further development.
The organic extracts of each of the two biologically active sponges8 were fractionated to yield, in the case of the Rhaphoxya sp. sample, one new (1) and three known (2-4) sesquiterpenes substituted with either isocyanato, isothiocyanato or isocyano (isonitrile) functionalities. The first compound isolated in this study, 1, was the least abundant, and also relatively unstable. The molecular formula of 1 was determined to be C16H25NO by accurate mass measurement. From the 1H and 13C NMR data of 1 (Table 1) only 21 proton and 14 carbon resonances were observed, indicating that at least one if not two of the proton and carbon resonances were degenerate. From the 1H and 13C NMR and UV data of 1 it was evident that the molecule contained a conjugated diene [13C NMR: 139.4 (C-7, C), 123.6 (C-8, CH), 123.5 (C-9, CH) and 140.5 ppm (C-10, C); UV-PDA 240 nm] and an isocyanato moiety [57.9 (C-3, C); 122.4 ppm (C-16, NCO, br)] as the only multiple bonds within the molecule, showing it to be monocyclic and very similar in structure to 2 and 3; the significant differences between them being the isocyanato moiety in 1, that also accounted for all of the heteroatoms within the molecule. HMBC correlations observed between the resonance for H3-13, and those for C-2, C-3, C-4 and C-16 showed C-2, C-4, C-13 and the nitrogen to bond directly with C-3 (see Supporting Information). From the magnitude of the 1H coupling constant between H-9 and H-10 (J = 15.3 Hz) it was evident that Δ9 had E geometry. The C-7/C-9 double -bond also had E geometry based on a 2D NOESY cross-peak between H-6 and H-8. Furthermore, comparison of the 13C-NMR data for 1 at C-3, C-6 and C-13 with the corresponding data for 2 and 3 (Tables 1 and S1) showed the three molecules to have the same relative configurations. Thus, 1 is the C-3 isocyanato derivative of theonellin isothiocyanate (2),9 and as such is best described as theonellin isocyanate. Compounds 1-3 are all optically inactive due to the plane of symmetry passing through C-3 and C-6.
Table 1. 1H (400 MHz CDCl3) and 13C NMR (100 MHz CDCl3) Spectroscopic Data for 1 and 2a.
No. | δC, mult. (1) | δH (J in Hz) (1) | δC, mult. (2) | δH (J in Hz) (2) |
---|---|---|---|---|
1 | 27.6, CH2 | 1.41, m; 1.64, m | 26.9, CH2 | 1.43, m; 1.72, m |
2 | 40.0, CH2 | 1.68, m; 1.84, m | 38.5, CH2 | 1.78, m; 1.89, m |
3 | 57.9, C | 60.9, C | ||
4 | 40.0, CH2 | 1.68, m; 1.84, m | 38.5, CH2 | 1.78, m; 1.89, m |
5 | 27.6, CH2 | 1.41, m; 1.64, m | 26.9, CH2 | 1.43, m; 1.72, m |
6 | 45.6, CH | 1.92, m | 45.0, CH | 1.96, m |
7 | 139.4, C | 138.8, C | ||
8 | 123.6, CH | 5.81, brd, (10.8) | 123.8, CH | 5.80, brd, (10.7) |
9 | 123.5, CH | 6.21, ddd, (1.2, 10.8, 15.3) | 123.4, CH | 6.20, ddd, (1.2, 10.7, 15.0) |
10 | 140.5, CH | 5.59, dd, (7.0, 15.3) | 140.7, CH | 5.59, dd, (7.1, 15.0) |
11 | 31.4, CH | 2.35, dqq, (7.0, 6.7, 6.7) | 31.4, CH | 2.35, dqq, (7.1, 6.8, 6.8) |
12 | 22.5, CH3 | 1.01, d, (6.7) | 22.5, CH3 | 1.01, d, (6.8) |
13 | 26.0, CH3 | 1.35, brs | 25.0, CH3 | 1.42, brs |
14 | 15.1, CH3 | 1.72, s | 15.2, CH3 | 1.72, s |
15 | 22.5, CH3 | 1.01, d, (6.7) | 22.5, CH3 | 1.01, d, (6.8) |
16 | 122.4, NCO (br) | 129.0, NCS |
All assignments are based on interpretation of extensive 1D and 2D NMR measurements
Together with 1 the three known compounds 2-49-11 were also isolated and fully characterised by NMR. For each of these compounds complete and unambiguous 1H and 13C-NMR data are provided in Tables 1 and S1. This is the first report of 2-4 co-occurring in the same organism. From our previous research12, 13 it is known that compounds with isocyanato, isothiocyanato or isocyano (isonitrile) functionalities are often biologically active and in the present case are the components responsible for at least some of the observed bioactivity of the original sponge extract. Unfortunately, the instability of 1-4 precluded us from proving this contention.
From the organic extract of the Suberea sp. sample five bromotyramine derivatives (5-9) were isolated, two of which were new compounds (5 and 6). The known compounds were psammaplysins A (7) and B (8),14 and moloka'iamine (9).13 Compound 5, analysed for C21H24Br3N3O6 by mass spectrometry. From the 1H and 13C and 2D NMR data of 5 (Table 2) it was evident the molecule contained 12 sp2 hybridized carbons, six of which were present as methines the remainder being quaternary carbons. From these data it was also clear that there were nine sp3 hybridized carbons indicating one methyl, six methylenes, one methine and one quaternary carbons. These deductions meant 5 had to contain four protons bound to either oxygen and/or nitrogen and that the molecule was tricyclic. The 1H NMR data showed the presence of a 1, 2, 4-tri-substituted phenyl group [δ7.52, d, 2.2 (H-15), δ7.24, dd, 2.2, 8.5 (H-17), δ7.05, d, 8.5 (H-18)]. The two proton resonances at δ 3.09 and 3.42 (CH2-5) displayed a large 16.0 Hz coupling, similar to that found in the 4,5-dihydro-1,2-oxazole moiety of fistularins16, 17 and in the 4,6-dibromo-5-methoxy-2,3-dihydrooxepine moiety of psammaplysins.14, 18-22 Closer inspection of the 13C NMR data of 5 clearly showed it was characteristic of a psammaplysin skeleton rather than a fistularin, particularly the characteristic resonance for the spiro-carbon C-6 (121.7 ppm). In fact, the C-1 to C-12 part of 5 was found to be identical to that of psammaplysins A (7)14 and F.20 The molecular formula of 5 indicated it differed from 7 by having one less bromine atom in the phenyl ring and from psammaplysin F by missing the same bromine as well as the methyl of the N-CH3 group. All of the physical and spectroscopic data of 5 supported this deduction, in particular the NOEs between the resonances for H2-12 and H-18, and those between H2-19 and H-15 and H-17, which confirmed the regio-chemistry of the phenyl ring. This is the ninth reported psammaplysin, psammaplysin I (5), and the first to contain a mono-bromo-tyramine moiety. Both biosynthetically and synthetically, mono-brominated tyramines are considerably more challenging to make than the equivalent 1,3-dibromo-analogues, and an obvious result of this is the much lower occurrence of the mono-brominated class in nature and in this sense they should be considered quite special.
Table 2. 1H (400 MHz, CD3OD) and 13C NMR (100 MHz, CD3OD) Spectroscopic Data for Psammaplysin I (5), Psammaplysin J (6), and COSY and gHMBC NMR data (400 MHz, CD3OD) for Psammaplysin I (5)a.
No. | δC, mult. (5) | δH (J in Hz) (5) | COSY (5) | gHMBC (5) | δC, mult. (6) | δH (J in Hz) (6) |
---|---|---|---|---|---|---|
1 | 147.6, CH | 7.17, s | 2, 3, 6 | 147.6, CH | 7.17, s | |
2 | 105.2, C | 105.2, C | ||||
3 | 150.7, C | 150.7, C | ||||
4 | 105.4, C | 105.4, C | ||||
5a | 39.2, CH2 | 3.09, d (16.0) | H-5a | 3, 4, 6 | 39.2, CH2 | 3.09, d, (16.0) |
5b | 3.42, d, (16.0) | H-5b | 3, 4, 6 | 3.42, d, (16.0) | ||
6 | 121.7, C | 121.7, C | ||||
7 | 81.3, CH | 5.01, s | 6, 8 | 81.3, CH | 5.01, s | |
8 | 159.6, C | 159.6, C | ||||
9 | 161.7, C | 161.7, C | ||||
10 | 38.8, CH2 | 3.59, m | H-11 | 9, 11 | 38.8, CH2 | 3.59, m |
11 | 30.9, CH2 | 2.13, m | H-10, 12 | 10, 12 | 30.9, CH2 | 2.13, m |
12 | 69.1, CH2 | 4.14, t, (6.0) | H-11 | 10, 11, 13 | 69.1, CH2 | 4.15, t, (6.0) |
13 | 156.9, C | 157.2, C | ||||
14 | 114.6, C | 113.7, C | ||||
15 | 135.4, CH | 7.52, d, (2.2) | H-17 | 13, 15, 18 | 132.3, CH | 7.66, d, (2.0) |
16 | 132.5, C | 136.8, C | ||||
17 | 132.8, CH | 7.24, dd, (2.2, 8.5) | H-15, 18 | 13, 15, 18 | 127.6, CH | 7.38, dd, (2.0, 8.5) |
18 | 115.8, CH | 7.05, d, (8.5) | H-17 | 13, 14, 16, 17 | 115.1, CH | 7.09, d, (8.5) |
19 | 34.2, CH2 | 2.91, t, (7.2) | H-20 | 15, 16, 17, 20 | 70.2, CH | 4.86, m |
20 | 42.8, CH2 | 3.17, t, (7.2) | H-19 | 16, 19 | 48.0, CH2 | 3.01, m 3.15, m |
21 NCH3 CONH NH OH | 60.2, CH3 | 3.68, s | 3 | 60.2, CH3 | 3.68, s |
All assignments are based on interpretation of extensive 1D and 2D NMR measurements
HMBC correlations are from proton(s) stated to the indicated carbons
Compound 6, was characterised based only upon its 1H and 13C NMR data (Table 2) as it could not be successfully separated chromatographically from 5 due to the very small amount of material (1.2 mg of an approximately 3:2 mixture of 6 and 5). As a result other unambiguous data (MS, IR, UV, [α]D) could not be recorded, however, by applying subtraction methods a complete and unambiguous set of 1H and 13C NMR data was obtained for future reference (Supporting Information and Table 2). Inspection of the 1H NMR data of the mixture indicated 6 was yet another psammaplysin derivative very similar to 5. When 1H and 13C NMR spectroscopic data for the two compounds were closely compared and subtraction spectra generated (Supporting Information) it was evident that the differences between the two were in the phenyl ring region (C-13 to C-20) and that these differences could only be explained by the presence of an OH group at C-19, rather than, for example, chlorine, bromine or sulphate, making 6 the 18-debromo-derivative of psammaplysin B,16 psammaplysin J. All of the NMR data recorded for 6 were consistent with this deduction. Upon completion of the planar structure analysis of 5 and 6, their relative configurations required assignment. Literature research revealed that stereochemical assignments for psammaplysins reported to date, A-H,14, 18-22 were based on data comparisons made with psammaplysin A whose relative configuration was determined by single crystal X-ray crystallographic analysis.14 In the 2D NOESY data of 5 it was apparent that there were no interactions between either of the protons attached to C-5 and H-7. On examining minimised structures of 5 with 6R*, 7R* and 6R*, 7S* configurations it was evident that the 6R*, 7R* configured molecule would be the one expected to show no NOE interactions between H2-5 and H-7. This information, combined with comparable specific rotation data as well as comparable 13C NMR chemical shifts for C-5, C-6 and C-7 and 1H NMR shifts for H2-5 and H-7 to that of the other psammaplysins14, 18-22 indicated 5 and 6 to have the same relative configurations as the ones previously reported. Based on our data it was not possible to make deductions concerning the configuration of C-19 in 6.
Previously reported biological activity data for psammaplysins14, 18-22 and the fact that poly-brominated compounds are unlikely to ever be progressed further than preliminary laboratory screening efforts due to their instability, no further biological evaluations of our materials were undertaken.
The results obtained from this study clearly supported our original contention that Twilight Zone organisms will almost certainly yield interesting and biologically active metabolites that are new to science. What was particularly interesting was that the two sponges selected at random from the group of organisms that were found to have a much higher than expected hit rate in pre-screening actually did yield new and known compounds that could, based on similar activities of already known compounds,12-15, 18-22 be generally associated with the observed activities of their original extracts.
Experimental Section
General Experimental Procedures
Optical rotation data was collected employing a Rudolph Research Analytical Autopol IV Automatic polarimeter. IR spectra were measured using a Thermo Scientific Nicole iS10 FTIR spectrophotometer fitted with a Smart iTR. NMR spectra for all compounds were measured on a Bruker Avance DRX 400 MHz NMR spectrometer. All NMR spectra were referenced to NMR solvent signals as follows (δ7.26 and 77.0 ppm for CDCl3, and δ3.34 and 49.9 ppm for CD3OD). FTICR-MS measurement, of 1, was performed on an unmodified Bruker BioAPEX 47e mass spectrometer equipped with an Analytica of Branford model 103426 (Branford, CT) electrospray ionisation (ESI) source in the positive mode. Direct infusion of the sample (0.2 mg/mL in MeOH) was carried out using a Cole Palmer 74900 syringe pump at a rate of 100 μL/h. The instrument was calibrated using a methanolic solution of CF3COONa (0.1 mg/mL MeOH). HRESIMS, of 5, was measured on a Applied Biosystems Mariner Biospectrometry TOF workstation using positive electrospray ionization, mobile phase 1:1 MeOH:H2O. HPLC separations were undertaken employing a Waters HPLC system with binary pumps (Waters 1525), Waters 717 auto-sampler and Waters 2996 PDA detector together with a Phenomenex Gemini C18, 5 um, 250 × 10 mm HPLC column.
Animal Material
The sponge Suberea sp., (Family Aplysinellidae) was collected in October, 2005 at Black Coral Kingdom, Guam (N13.31.98, E144.63.93), from a depth of 60 m. The sponge is light tan colored and its growth form is massive spreading across the substrate. The surface is smooth with a pronounced conules; the consistency is rubbery and spongy. The sponge colors dark after preservation. The skeleton is composed of very sparse dendric fibres in relation to the soft tissue. The fibres are in cross-section composed of both bark and pith elements. Thirteen species has been assigned to the genus Suberea. All of these, with exception of Suberea creba, are clearly differrent from the Guam specimen either by growth form and/or color. The Guam specimen is most related to S. creba from New Caledonia. The growth form and color is similar, but the surface, consistency and fibre diameter differs. We believe that the current specimen is an undescribed species.
The sponge Rhaphoxya sp., (Family Dictyonellidae) was collected near Blue Hole, Guam (N13.26.20, E144.37.42), at a depth of 90 m, along a drop off, in July, 2006. The sponge is tan colored and the growth form is massive to subspherical; the consistency is spongy and compressible. The skeleton is composed of vague diverging meandering spicule tracts ascending towards the surface with many broken spicule fragments lying loose in the heavily collagenous soft tissue. The majority of the megascleres are flexuous strongyles, although the terminations of the spicules vary from symmetrical to hastate tapering ends or more telescoped ends. The dimensions of the spicules are 350-550 × 2-5 μm. Seven other species are presently assigned to the genus Rhaphoxya, but are known from Southern Australia with exception of R. laubenfelsi (Mexico) and R. systremma (New Caledonia). The Mexican species is a branching sponge, with a different spicule composition. The most related species is R. systremma, with a known distribution on the Great Barrier Reef and New Caledonia. It differs mainly from the Guam specimen in the dimensions of the spicules. We believe that the Guam specimen is an undescribed species. Both sponges were kept at ambient temperature in seawater in a cooler during transport to the laboratory where they were immediately frozen at −20°C. Collection was carried out according to local (Guam) legislation. Voucher specimens (Accession number RMNH POR. 3005 and 3014, respectively) have been lodged with the NCB Naturalis, Leiden, Netherlands.
Extraction and Isolation
Freeze-dried Rhaphoxya sp., material (60 g) was exhaustively extracted with MeOH/EtOAc (1:1) to yield 13.2 g of extract. This extract was redissolved in 300 mL MeOH/H2O (9:1) and partitioned with an equivalent volume of n-hexane. The resultant bioactive n-hexane-fraction (520 mg) material was dried and further separated employing flash chromatography (Silica gel 60, 40-63 μm, 0%-100% EtOAc:n-hexane) to yield 12 semi-pure fractions each of 200 mL. Fractions were evaporated under reduced pressure and aliquots tested against the whole assays panel.8 Active fractions were further purified by HPLC employing a silica column (Phenomenex column Luna 3μm, 250 × 4.6 mm) and isocratic elution with n-hexane:EtOAc (98:2) and a flow rate of 0.5 mL/min affording compounds 1 .(0.9 mg, 0.002 %), theonellin isothiocyanate (2):9 (18.5 mg, 0.03 %), theonellin isocyanide (3):10 (26.1 mg, 0.044 %), and 7-isothiocyanato-7, 8-dihydro-α-bisabolene (4):11 (2.6 mg, 0.004 %); [α]25D +54 (c 0.02, CH3OH) [lit. +60.5 (c 6.8, CDCl3)11].
Theonellin Isocyanate (1)
clear oil. UV (PDA, CH3OH/H2O) λmax 240 nm; 1H (400 MHz, CD3OD) and 13C (100 MHz, CD3OD) NMR data see Table 1; FT-ICR-HRESIMS m/z 270.1836 [M+Na]+, (calcd for C16H25NONa, 270.1828).
The sponge Suberea sp. was freeze-dried and the dry material (30 g) exhaustively extracted with MeOH/EtOAc (1:1) to yield 4.0 g of extract. This extract was redissolved in 200 mL of MeOH/H2O (9:1) and partitioned with an equivalent volume of n-hexane. The resultant bioactive aqueous MeOH fraction (2.45 g) was dried under reduced pressure and subjected to reversed-phase (RP) C18 vacuum liquid column chromatography (40%, 45%, 50% 55%, 60%, 65%, 70%, 80%, 90%, 100% MeOH:H2O) to yield 10 fractions each of 400 mL. Testing of the fractions in the whole assays panel,10 indicated the 45% and 50% MeOH fractions to be active. These were combined and further separated by C18 vacuum liquid column chromatography (5-100% MeOH:H2O). Final purification of these semi-pure fractions was achieved by RP HPLC (250 × 10 mm, Phenomenex Gemini C18 column, 5 μm) using a flow rate of 3 mL/min and gradient elution from 60% MeOH (+ 0.1% formic acid) to 100% MeOH (+ 0.1% formic acid) in 15 mins to yield compounds to yield compounds 5 (5.0 mg, 0.008%), 6+5 (3:2 mixture; 1.2 mg, 0.002%), psammaplysin A (7)14 (1.3 mg, 0.002%); [α]25D −48 (c 0.05, CH3OH) [lit. −65 (c 0.05, CH3OH)14]; psammaplysin B (8)14 (5.4 mg, 0.009%); [α]25D −61.5 (c 0.04, CH3OH) [lit. −60.2 (c 0.632,CH3OH)14], and moloka'iamine (9)15 (4.0 mg, 0.006%).
Psammaplysin I (5)
Light yellow amorphous powder. [α]25D −90 (c 0.35, CH3OH); UV (PDA, CH3OH/H2O); λmax 280 sh, 250 sh, 218 nm; IR (neat) νmax 3387, 3243, 2926, 1670, 1200, 1140 cm−1; 1H (400 MHz, CD3OD) and 13C (100 MHz, CD3OD) NMR data see Tables 1 and 2; HRESIMS m/z 655.9247 [M]+, (calcd for C21H2581Br279BrN3O6, 655.9252).
Psammaplysin J (6)
3:2 mixture with psammaplysin I (5); light yellow amorphous solid. UV (PDA, CH3OH/H2O); λmax 280 sh, 250 sh, 218 sh nm; 1H (400 MHz, CD3OD) and 13C (100 MHz, CD3OD) NMR data see Tables 1 and 2.
Supplementary Material
Acknowledgments
We are indebted to J. Pinson for his assistance with sample collection. This research was supported in part by 5U56CA096278 grants awarded by the National Cancer Institute and NIH MBRS SCORE grant S06-GM-44796.
Footnotes
Dedicated to Dr. Gordon M. Cragg, formerly Chief, Natural Products Branch, National Cancer Institute, Frederick, Maryland, for his pioneering work on the development of natural product anticancer agents.
Supporting Information Available: Spectra in the file are: 1H NMR spectral data for all isolated compounds together with selected 2D NMR spectra of some of the known compounds, and 1H and 13C NMR (via HMBC for 6) as well as selected 2D NMR spectra for compounds 1, 5, and 6, together with complete unambiguous 1H and 13C NMR data for compounds 3, 4 and 10 in Table S1, as well as laboratory photographs of the two sponges and are available free of charge via the Internet at http://pubs.acs.org.
References and Notes
- 1.Tapiolas DM, Bowden B, Motti CA, Willis RH, Abou-Mansour E, Bourne D, Doyle JR, Llewellyn L, Wright AD. J Nat Prod. 2009;72:1115–1120. doi: 10.1021/np900099j. [DOI] [PubMed] [Google Scholar]
- 2.Keyzers RA, Northcote PT, Davies-Coleman MT. Nat Prod Rep. 2006;23:321–334. doi: 10.1039/b503531g. [DOI] [PubMed] [Google Scholar]
- 3.Cragg GM, Newman DJ, Yang SS. J Nat Prod. 2006;69:488–498. doi: 10.1021/np0581216. [DOI] [PubMed] [Google Scholar]
- 4.Look SA, Fenical W, Matsumoto GK, Clardy J. J Org Chem. 1986;51:5140–5143. [Google Scholar]
- 5.Stanley NF. Chapter 7, Agars. In: Stephen AM, Phillips GO, Williams PA, editors. Food polysaccharides and their applications. 2nd CRC Press; 2006. [Google Scholar]
- 6.MarinLit, Version 2010. A marine literature database produced and maintained by the Department of Chemistry, University of Canterbury, New Zealand.
- 7.Wright AD, McCluskey A, Robertson MJ, MacGregor KA, Gordon CP, Guenther J. Org Biomol Chem. 2011;9:400–407. doi: 10.1039/c0ob00326c. [DOI] [PubMed] [Google Scholar]
- 8.Schupp P, Kohlert-Schupp C, Whitefield S, Engemann A, Hemscheidt T, Pezzuto JM, Kondratyuk TP, Park EJ, Marler L, Rostama B, Wright AD. Nat Prod Comm. 2009;4:1717–1728. [PMC free article] [PubMed] [Google Scholar]
- 9.Nakamura H, Kobayashi J, Ohizumi Y. Tetrahedron Lett. 1984;25:5401–5404. [Google Scholar]
- 10.Gulavita NK, de Silva ED, Hagadone MR, Karuso P, Scheuer PJ, Van Duyne GD, Clardy J. J Org Chem. 1986;51:5136–5139. [Google Scholar]
- 11.Sullivan BW, Faulkner DJ, Okamoto KT, Chen MHM, Clardy J. J Org Chem. 1986;51:5134–5136. [Google Scholar]
- 12.Wright AD, G M König G, Angerhofer CK, Greenidge P, Linden A, Desqueyroux-Faundez R. J Nat Prod. 1996;59:710–716. doi: 10.1021/np9602325. [DOI] [PubMed] [Google Scholar]
- 13.Wright AD, Wang H, Gurrath M, König GM, Kocak G, Neumann G, Loria P, Foley M, Tilley L. J Med Chem. 2001;44:873–885. doi: 10.1021/jm0010724. [DOI] [PubMed] [Google Scholar]
- 14.Roll DM, Chang CWJ, Scheuer PJ, Gray GA, Shoolery JN, Matsumoto GK, Van Duyne GD, Clardy J. J Am Chem Soc. 1985;107:2916–2920. [Google Scholar]
- 15.Hamann MT, Scheuer PJ, Kelly-Borges M. J Org Chem. 1993;58:6565–6569. [Google Scholar]
- 16.Gopichand Y, Schmitz FJ. Tetrahedron Lett. 1979:3921–3924. [Google Scholar]
- 17.Gunasekera SP, Susan S, Cross SS. J Nat Prod. 1992;55:509–512. doi: 10.1021/np50082a020. [DOI] [PubMed] [Google Scholar]
- 18.Copp BR, Ireland CM, Barrows LR. J Nat Prod. 1992;55:822–823. doi: 10.1021/np50084a021. [DOI] [PubMed] [Google Scholar]
- 19.Ichiba T, Scheuer PJ, Kelly-Borges M. J Org Chem. 1993;58:4149–4150. [Google Scholar]
- 20.Liu S, Fu X, Schmitz FJ, Kelly-Borges M. J Nat Prod. 1997;60:614–615. doi: 10.1021/np970070s. [DOI] [PubMed] [Google Scholar]
- 21.Yang X, Davis RA, Buchanan MS, Duffy S, Avery VM, Camp D, Quinn RJ. J Nat Prod. 2010;73:985–987. doi: 10.1021/np900834g. [DOI] [PubMed] [Google Scholar]
- 22.Xu M, Andrews KT, Birrell GW, Tran TL, Camp D, Davis RA, Quinn RJ. Bioorg Med Chem Lett. 2011;21:846–848. doi: 10.1016/j.bmcl.2010.11.081. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.